Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal surface-based morphometry reveals potential MRI biomarkers correlated with multidimensional brain health measures.

Brain imaging and behavior·2026
Same author

Pressure points: A pilot study using the NASA-TLX tool to measure the intensity of Acute care surgery work.

American journal of surgery·2026
Same author

Near-Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute-Designated Cancer Center: Mixed Methods Implementation Study.

JMIR medical informatics·2026
Same author

Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients.

Current oncology (Toronto, Ont.)·2026
Same author

A Geographic Disparities Analysis Between Standard of Care and Clinical Trial CAR-T Patients in Kansas.

Cancer medicine·2026
Same author

A 5-year retrospective review of post-Mohs reconstruction outcomes for periocular cutaneous malignancies at an academic medical center.

Frontiers in ophthalmology·2026

Related Experiment Video

Updated: Jan 8, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K

Predicting dementia risk using neuroimaging and cognitive assessment.

Yu Wang1, William Guiler2, Ankit Patel2

  • 1Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA.

JAR Life
|December 22, 2025
PubMed
Summary

Combining brain imaging with cognitive tests improves dementia risk prediction. This multimodal approach offers a scalable method for early detection and personalized care in aging populations.

Keywords:
BiomarkersCognitive assessmentDementiaNeuroimagingStructural MRI

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

761
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Related Experiment Videos

Last Updated: Jan 8, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.2K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

761
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Area of Science:

  • Neuroscience
  • Gerontology
  • Medical Imaging

Background:

  • Dementia affects over 55 million globally, with numbers projected to double.
  • Current dementia risk assessments often fall short, necessitating improved early detection methods.
  • Integrating structural brain imaging with cognitive assessments may enhance dementia risk prediction accuracy.

Purpose of the Study:

  • To evaluate the efficacy of combining structural brain imaging and brief cognitive assessments for predicting dementia risk.
  • To compare the predictive power of single-visit versus longitudinal modeling approaches.
  • To identify key neuroimaging and cognitive markers associated with dementia risk.

Main Methods:

  • Utilized data from 312 older adults from the KU Alzheimer's Disease Center cohort.
  • Employed cognitive testing and MRI scans measuring hippocampal volume, gray matter, and Alzheimer's disease signature regions.
  • Assessed depressive symptoms using the Geriatric Depression Scale (GDS) and analyzed both single-visit and longitudinal data.

Main Results:

  • Multimodal models incorporating neuroimaging significantly outperformed those relying solely on demographics or cognitive scores.
  • The optimal model, combining imaging and cognitive data, achieved 77.6% accuracy in predicting dementia status.
  • Reduced hippocampal volume, lower gray matter, and higher GDS scores were identified as key predictors, suggesting an interaction between depression and neurodegeneration.

Conclusions:

  • A compact, multimodal approach using standard MRI and brief cognitive tests can generate clinically relevant individualized dementia risk profiles.
  • This method provides a scalable pathway for early intervention, clinical trial enrollment, and personalized care planning.
  • Future research will focus on diverse population validation and integration of fluid biomarkers to refine dementia risk prediction.